MDA Space's U.S. IPO Prices at $30.50 — But Can the Stock Keep Climbing Above Its Offer Price?

Shares of MDA Space Ltd. surged past their initial public offering price this week, trading at $34.25 — a 12.3% premium to the $30.50 IPO price — as investors signaled confidence that the Canadian space technology company's U.S. listing marks a credible growth chapter rather than a dilutive cash grab. MDA Space Prices Its U.S. IPO at $30.50 — Can a $4 Billion Space Company Keep Riding Satellite Demand Above Its Offering Price?

Shares shifted as MDA Space, Canada's largest space technology firm, saw its stock climb to $34.25 — well above the $30.50 U.S. IPO price — after its dual-listing on the NYSE drew fresh capital and broadened its investor base. The question now is whether the company's fundamentals justify the rally or if new shareholders are simply chasing momentum.

• The IPO Raised $341 Million — And the Company Already Spent Down Its Backlog to Earn It

MDA issued roughly 9.8 million shares at $30.50, generating about $300 million in gross proceeds.

Underwriters then exercised their over-allotment option for an additional 1.3 million shares, pushing total gross proceeds to approximately $341 million.

Net equity proceeds of $441.5 million (including Canadian tranche proceeds) lifted cash to $544 million and cut long-term debt to $245 million. That's a materially stronger balance sheet — but it came with dilution.

• Revenue Is Surging, But New Orders Needed Watching

Q2 2026 revenue hit $498.6 million, up 33.6% year-over-year, with growth across all business segments.

Backlog rebounded to $4.0 billion, up $310 million from Q1, driven by bookings that outpaced the conversion of existing orders into revenue. That's a critical reversal — in Q1, order bookings had plunged to just $143.9 million versus $803.9 million a year earlier , which spooked some analysts. Q2 bookings recovered to $808.9 million , easing concerns about demand durability.

• The U.S. Listing Is About More Than Capital — It's an M&A Currency

MDA's CEO said the U.S. ticker makes the company "more accessible to American investors" and positions it to pursue acquisitions in the U.S. and Europe.

Management has flagged a $40 billion opportunity pipeline spanning commercial and government contracts over five years. A liquid NYSE-listed stock gives MDA the ability to use its own shares, rather than cash, to buy competitors — a meaningful strategic advantage in a consolidating space industry.

• Dilution Is Real, But Growth May Outrun It

Diluted earnings per share growth was tempered by the "increase in the average number of common shares outstanding following the Company's initial public offering."

Still, adjusted EBITDA (a measure of operating profit before accounting charges) reached $96.3 million in Q2, with margins of 19.3%, consistent with full-year guidance of 18–20%. If revenue keeps compounding above 30% while margins hold, the dilution math works. If growth decelerates, those extra shares will weigh heavier.